Evidence map›Paper›PMID 36748089›Full record

ArticlePeerJ2023

Investigation of the hydration process and biological activity of a novel nanosilver incorporated dicalcium silicate based retrograde filling material.

Teena Dsouza, Aditya Shetty, Sudarshan Kini, Veena Shetty, Shama Rao, Rajesha Payaradka, Nijil Satheesan, Neevan Dsouza, Heeresh Shetty

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Teena DsouzaAB Shetty Memorial Institute of Dental Sciences, Nitte (Deemed to be University), Mangalore, India.
Aditya ShettyAB Shetty Memorial Institute of Dental Sciences, Nitte (Deemed to be University), Mangalore, India.
Sudarshan KiniNitte University Centre for Science and Educational Research, Nitte (Deemed to be University), Mangalore, India.
Veena ShettyKS Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, India.
Shama RaoTexas A&M University, Texas, United States of America.
Rajesha PayaradkaKS Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, India.
Nijil SatheesanNitte University Centre for Science and Educational Research, Nitte (Deemed to be University), Mangalore, India.
Neevan DsouzaKS Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, India.
Heeresh ShettyNair Hospital Dental College, Mumbai, India.
Nitte University · INK S Hegde Medical Academy · INTexas A&M University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although several materials have been used for retrograde filling following apical surgeries, there is no consensus on a single best material. Tricalcium silicate-based types of cement have been developed as root-end filling materials mainly due to tricalcium silicate's hydraulic properties. However, its unfavorable setting characteristics and minimal antimicrobial properties have necessitated the introduction of new additives into the existing commercially available materials. To design an affordable product based on a dicalcium silicate with a shorter set time, minimal cytotoxic complications, and enhanced antibacterial activity, we developed a new endodontic cement from pure raw materials, intending to satisfy the prerequisites of ideal retrograde material. Methods: The composition of the experimental calcium silicate-based cement included the addition of calcium chloride and silver nanoparticles in varying concentrations. Structural characterization was carried out using energy dispersive analysis by X-rays using scanning electron microscope (EDAX SEM) and hydration characteristics were performed using an X-ray diffractometer (XRD). The experimental material was further evaluated for biocompatibility using MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)assay and antibacterial activity was evaluated using an agar diffusion test against Results: The structural characterization and hydration characteristics revealed that the experimental cement was dicalcium silicate based with favorable biocompatibility and enhanced antibacterial activity. Tricalcium silicate based mineral trioxide aggregate (MTA) also had favourable biocompatibility, however, its antibacterial activity was significantly decreased when compared to the novel cement. Conclusion: All hydraulic cements that are available in the dental market are predominantly tricalcium silicate-based materials. There has been no evidence in the literature to date wherein it has been explored whether a dicalcium silicate-based hydraulic cement can solely be used in root-end cavities. The findings of the study revealed a dicalcium silicate based retrograde filling material with favourable biocompatibility exhibited immediately as well as in the set samples. Incorporation of silver nanoparticles boosted the antibacterial activity when compared to that of ProRoot MTA. This material could potentially reinstate the usual hype created with tricalcium silicate types of cement since dicalcium silicate cements also exhibit similar properties.

Indexed as

Metal NanoparticlesOxidesAnti-Bacterial AgentsCalcium CompoundsGlass Ionomer CementsMaterials TestingSilicatesSilverX-Ray DiffractionAnti-Bacterial AgentsCalcium Compoundsdicalcium silicateGlass Ionomer CementsOxidesSilicatesSilvertricalcium silicateBiocompatibilityCalcium silicateNanosilverRetrograde filling

Identifiers

PMID36748089
PMCPMC9899052
OpenAlexW4318819741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.